Jupiter Wellness Appoints Nancy Torres Kaufman to Its Board of Directors

Rhea-AI Summary

Jupiter Wellness (NASDAQ:JUPW) has appointed Nancy Torres Kaufman to its board of directors. Kaufman is the founder and CEO of Beacon Capital, which has helped guide 39 life sciences companies, raising $1.5 billion. Her expertise in identifying high-impact firms aligns with Jupiter's goals to advance its clinical pipeline and expand its OTC product offerings. Kaufman emphasized her commitment to sustainable and innovative healthcare solutions, highlighting Jupiter's diverse CBD product portfolio and ongoing FDA clinical trials.

Positive

• Nancy Torres Kaufman's appointment strengthens Jupiter's leadership with her extensive experience in life sciences.
• Kaufman's firm has successfully guided 39 companies, indicating a strong potential for value addition at Jupiter.
• The partnership aims to enhance the life sciences ecosystem in Jupiter, possibly attracting additional investment and collaboration.

Negative

• None.

Life sciences investor and founder of Beacon Capital focused on identifying strong management teams with breakthrough technologies.

JUPITER, FL / ACCESSWIRE / January 26, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced that Nancy Torres Kaufman has joined its board of directors.

Ms. Torres Kaufman is Founder, Chairman, and CEO of Beacon Capital, a family office an investment and advisory firm focused in the therapeutic space. She leads the firm in identifying, investing in, and working with strong management teams with excellent track records and the knowledge and drive to develop life science breakthroughs. Since 2010, Ms. Kaufman and her firm have guided 39 early-to-late-stage life sciences companies which received $1.5 billion via the principal and or advisory activities of Beacon Capital and affiliated families. Many of these companies have flourished as private and public companies, while others were acquired by big pharma.

Based in Jupiter, Florida Ms. Kaufman and Beacon Capital are developing the Beacon Pharmaceutical Jupiter venture, a Life Sciences Accelerator LEED super smart facility comprised of state-of-the-art physical space and multimodal biologics manufacturing capabilities to be operated by a world class CDMO. A partnership with the town of Jupiter Florida to cement and expand the life Science ecosystem, which is current home of Scripps, Max Planck Institutes, and Florida Atlantic University (FAU) and many others.

Ms. Torres Kaufman, a Cuban emigrant left to the U.S. in 1994 as an unaccompanied minor. In 1999, she was awarded a full academic scholarship to the College of St. Elizabeth for BS/MD program with University of Medicine and Dentistry of New Jersey. Ms. Torres Kaufman entered the Women's Leadership Program at Yale School of Management in 2020.

"We are pleased and honored to have Nancy join our board of directors. Her experience identifying and supporting high-potential, high-impact life sciences companies is an asset to Jupiter as we advance our clinical pipeline and grow our OTC product portfolio and distribution platforms. We admire her leadership, both locally in our community in Jupiter, and the impact her life science investments and leadership have on a global scale," commented Brian John, CEO of Jupiter Wellness.

"Value-driven, sustainable and innovative: these words define our mission to work with like-minded companies to deliver therapeutics to transform patient health. Jupiter Wellness epitomizes these values and stands out for two very compelling reasons: a strong environmentally friendly revenue generating OTC portfolio and, a therapeutic pipeline of cannabidiol (CBD) assets making its way through FDA clinical trials. We look forward to being a catalyst and resource to Jupiter Wellness to drive value and assist management in the expansion of its clinical pipeline as we work to elevate and develop the Jupiter Florida Life Science Cluster." Stated Nancy Torres Kaufman

About Jupiter Wellness
Jupiter Wellness, Inc. (NASDAQ:JUPW) is a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products. The Company's clinical pipeline of prescription CBD-enhanced skin care therapeutics address indications including eczema, burns, herpes cold sores, and skin cancer. Jupiter generates revenues from a growing line of proprietary over-the-counter skincare products including its flagship CaniSun™ sunscreen and other wellness brands sold through its robust distribution platform.

For additional information, please visit www.jupiterwellnessinc.com. The Company's public filings can be found at www.Sec.gov.

Safe Harbor Statement
To the extent any statements contained in this presentation of Jupiter Wellness, Inc. (the "Company") contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 and the information that are based upon beliefs of, and information currently available to, the company's management as well as estimates and assumptions made by the company's management. These statements can be identified by the fact that they do not relate strictly to historic or current facts. When used in this presentation the words "estimate," "expect," intend," believe," plan," "anticipate," "projected" and other words or the negative of these terms and similar expressions as they relate to the company or the company's management identify forward-looking statements. Such statements reflect the current view of the company with respect to future events and are subject to risks, uncertainties, assumptions and other factors relating to the company's industry, its operations and results of operations and any businesses that may be acquired by the company. Should one or more of these risks or uncertainties materialize, or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Although the company believes that the expectations reflected in the forward-looking statements are reasonable, the company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the security laws of the United States, the company does not intend to update any of the forward-looking statements to conform these statements to actual results.

Investor & Public Relations Contact Info
Phone: 561-244-7100
Email: info@jupiterwellnessinc.com

SOURCE: Jupiter Wellness, Inc.

View source version on accesswire.com:
https://www.accesswire.com/625885/Jupiter-Wellness-Appoints-Nancy-Torres-Kaufman-to-Its-Board-of-Directors

FAQ

Who has joined Jupiter Wellness' board of directors?

Nancy Torres Kaufman has been appointed to the board of directors of Jupiter Wellness.

What experience does Nancy Torres Kaufman bring to Jupiter Wellness?

Kaufman is the founder and CEO of Beacon Capital, with a track record of guiding life sciences companies and raising $1.5 billion.

How will Nancy Torres Kaufman's appointment impact Jupiter Wellness?

Her expertise in identifying high-potential companies is expected to enhance Jupiter's clinical pipeline and OTC product offerings.

When was Nancy Torres Kaufman appointed to Jupiter's board?

Nancy Torres Kaufman was appointed to the board of Jupiter Wellness on January 26, 2021.

What is the focus of Jupiter Wellness' product development?

Jupiter Wellness develops cannabidiol (CBD) based medical therapeutics and wellness products, including prescription and OTC offerings.